The validity of predicting prognosis by the number of lymph node metastases in node-positive colon cancer


Background: We examined the possibility of predicting prognosis by the number of lymph node metastases. Methods: Two hundred and forty nine patients with lymph node metastases who underwent curative surgery for colon cancer were enrolled in this study. We calculated cancer-specific survival according to the number of lymph node metastases. Results: There was a tendency toward better rates of cancer-specific survivals among the patients with 1 LNM, compared with those with 2 LNM (p = 0.07). When comparing cancer-specific survival between the patients with 1, 2-3 and 4 or more lymph node metastases, cancer-specific survival was well stratified (p < 0.0001). With regard to stage classification, in the Japanese classi-fication, there was a significant difference in cancer-specific survival between Stages IIIa and IIIb (p < 0.0001). On the other hand, in the TNM classification, cancer-specific survival in Stages IIIA, IIIB and IIIC were stratified into three groups with significant differences (IIIA vs. IIIB; p = 0.007, IIIB vs. IIIC; p < 0.0001). Conclusion: It appeared to be valid to stratify cancer-specific survival into three groups, i.e., the patients with 1, 2 and 3 and 4 or more lymph node metastases. This study was in favor of the TNM classification in which N category is classified by the number of lymph node metastases.

Share and Cite:

Sugimoto, K. , Kawai, M. , Takehara, K. , Tashiro, Y. , Munakata, S. , Nagayasu, K. , Niwa, K. , Ishiyama, S. , Komiyama, H. , Takahashi, M. , Kojima, Y. , Goto, M. , Tomiki, Y. and Sakamoto, K. (2013) The validity of predicting prognosis by the number of lymph node metastases in node-positive colon cancer. Open Journal of Gastroenterology, 3, 217-222. doi: 10.4236/ojgas.2013.34036.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J. and Thun, M.J. (2009) Cancer statistics, 2009. CA: A Cancer Journal for Clinicians, 59, 225-249. doi:10.3322/caac.20006
[2] Watanabe, T., Itabashi, M., Shimada, Y., Tanaka, S., Ito, Y., Ajioka, Y., Hamaguchi, T., Hyodo, I., Igarashi, M., Ishida, H., Ishiguro, M., Kanemitsu, Y., Kokudo, N., Muro, K., Ochiai, A., Oguchi, M., Ohkura, Y., Saito, Y., Sakai, Y., Ueno, H., Yoshino, T., Fujimori, T., Koinuma, N., Morita, T., Nishimura, G., Sakata, Y., Takahashi, K., Takiuchi, H., Tsuruta, O., Yamaguchi, T., Yoshida, M., Yamaguchi, N., Kotake, K., Sugihara, K. and Japanese Society for Cancer of the Colon and Rectum (2012) Japanese society for cancer of the colon and rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. International Journal of Clinical Oncology, 17, 1-29. doi:10.1007/s10147-011-0315-2
[3] Griffin, M.R., Bergstralh, E.J., Coffey, R.J., Beart, R.W. and Melton, L.S. (1987) Predictors of survival after curative resection of carcinoma of the colon and rectum. Cancer, 60, 2318-2324. doi:10.1002/1097-0142(19871101)60:9<2318::AID-CNCR2820600934>3.0.CO;2-B
[4] Steinberg, S.M., Barkin, J.S., Kaplan, R.S. and Stablein, D.M. (1986) Prognostic indicators of colon tumors: The Gastrointestinal Tumor Study Group experience. Cancer, 57, 1866-1870. doi:10.1002/1097-0142(19860501)57:9<1866::AID-CNCR2820570928>3.0.CO;2-T
[5] Compton, C.C. (2000) Prognostic factors in colorectal cancer: College of American Pathologists Consensus Statement 1999. Archives of Pathology & Laboratory Medicine, 124, 979-994.
[6] Wong, S.K., Jalaludin, B.B., Henderson, C.J., Morgan, M.J., Berthelsen, A.S., Issac, M.M. and Kneebone, A. (2008) Direct tumor invasion in colon cancer: Correlation with tumor spread and survival. Diseases of the Colon & Rectum, 51, 1331-1338. doi:10.1007/s10350-008-9274-8
[7] Lim, S.B., Yu, C.S., Jang, S.J., Kim, T.W., Kim, J.H. and Kim, J.C. (2010) Prognostic significance of lymphovas cular invasion in sporadic colorectal cancer. Diseases of the Colon & Rectum, 53, 377-384. doi:10.1007/DCR.0b013e3181cf8ae5
[8] Dukes, C.E. and Bussey, H.J. (1958) The spread of rectal cancer and its effect on prognosis. British Journal of Cancer, 12, 309-320. doi:10.1038/bjc.1958.37
[9] Gastrointestinal Tumor Study Group (1984) Adjuvant therapy of colon cancer: Results of a prospectively randomized trial. New England Journal of Medicine, 310, 737-743. doi:10.1056/NEJM198403223101201
[10] Chapuis, P.H., Dent, O.F., Bokey, E.L., Newland, R.C. and Sinclair, G. (2004) Adverse histopathologic findings as a guide to patient management after curative resection of node-positive colonic cancer. British Journal of Surgery, 91, 349-354. doi:10.1002/bjs.4389
[11] National Institute of Health Consensus Conference (1990) Adjuvant therapy for patients with colon and rectal cancer. JAMA, 264, 1444-1450.
[12] Moeriel, C.G. (1994) Chemotherapy for colorectal cancer. New England Journal of Medicine, 330, 1136-1142. doi:10.1056/NEJM199404213301608
[13] Sobin, L.H., Gaspodarowicz, M. and Wittekind, C. (2009) TNM classification of malignant tumors. 7th Edition, Wiley-Blackwell, New York, 100-105.
[14] Japanese Society for Cancer of the Colon and Rectum (2009) Japanese Classification of Colorectal Carcinoma. 2nd English Edition, Kanehara & Co. Ltd., Tokyo, 7-10.
[15] Gunderson, L.L., Jessup, J.M., Sargent, D.J., Greene, F.L. and Stewart, A.K. (2010) Revised TN categorization for colon cancer based on national survival outcomes data. Journal of Clinical Oncology, 28, 264-271. doi:10.1200/JCO.2009.24.0952
[16] Cohen, A.M., Tremiterra, S., Candela, F., Thaler, H.T. and Sigurdson, E.R. (1991) Prognosis of node-positive colon cancer. Cancer, 67, 1859-1861. doi:10.1002/1097-0142(19910401)67:7<1859::AID-CNCR2820670707>3.0.CO;2-A
[17] Wang, W.S., Chen, P.M., Chiou, T.J., Liu, J.H., Fan, F.S., Lin, T.C., Jiang, J.K., Yang, S.H., Yen, C.C., Wang, H.S. and Lin, J.K. (2000) Factors predictive of survival in patients with node-positive colorectal cancer in Taiwan. Hepatogastroenterology, 47, 1590-1594.
[18] Vaccaro, C.A., Bonadeo, F.A., Benati, M.L., Quintana, G.M., Rubinstein, F., Mullen, E., Telenta, M. and Lastiri, J.M. (2004) Colorectal cancer staging: Reappraisal of N/ PN classification. Diseases of the Colon & Rectum, 47, 66-69. doi:10.1007/s10350-003-0004-y
[19] Mori, T. (2010) A comparison of the new (planned) TNM classification and Japanese general rule for staging colorectal cancer. Cancer Investigation, 28, 387-392.
[20] Gunderson, L.L., Jessup, J.M., Sargent, D.J., Greene, F.L. and Stewart, A. (2010) Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes. Journal of Clinical Oncology, 28, 256-263. doi:10.1200/JCO.2009.23.9194
[21] Kobayashi, H., Ueno, H., Hashiguchi, Y. and Mochizuki, H. (2006) Distribution of lymph node metastasis is a prognostic index in patients with stage III colon cancer. Surgery, 139, 516-522. doi:10.1016/j.surg.2005.09.004

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.